ANPII Bio advocates technical criteria for regulating bioinputs

The Bioinputs Law (No. 15.070/2024) is being drafted by a working group coordinated by the Ministry of Agriculture and Livestock (MAPA). ANPII Bio, representing the biologicals industry, is working to structure the legal framework on technically sound, safe, and innovation-friendly foundations.

The association advocates for science-based regulation and proportional risk, with reduced bureaucracy, adapted quality control, and encouragement of innovation. It also proposes tax incentives and recognition of the multifunctionality of bioinputs, with a focus on strengthening the national industry.

The sector generated R$5,7 billion in revenue in the last harvest. Growth is expected to grow by 60% by 2030. According to ANPII Bio's director of institutional relations, Julia Emanuela de Souza (in the photo), it is essential that regulations guarantee coexistence between industrial and on-farm production, in addition to attracting investment in research and commercialization.

According to Marcus Coelho, coordinator of the Ministry of Agriculture's Corbio/Diagro program, the biggest challenge is creating standards that expand the use of bioinputs without compromising quality and safety. He emphasizes the importance of technical training and access to reliable information.

With a technical and proactive approach, ANPII Bio collaborates on draft standards, technical notes, and impact studies. It engages with MAPA, ANVISA, and IBAMA to propose viable and well-founded regulations. It represents companies of all sizes and specializations, including growing segments such as biological inputs for animal use.

The main axes advocated include: acceptance of internationally compatible data, flexible registration criteria, and industry-validated methodologies. The entity seeks an innovative and secure regulatory environment, aligned with international labeling and toxicological safety standards.

The multifunctionality of bioinputs requires registrations that consider their various agronomic functions. A single product can act as both a biostimulant and a biodefensive. Without unified registration, companies face unnecessary costs and delays.

Quality control is also a key focus of the regulations. ANPII Bio proposes risk-based requirements and differentiated protocols for microorganisms, macroorganisms, and substances. In industrial production, it requires traceability. In biofactories with traditional active ingredients and safe use, it advocates simplified rules.

For on-farm production, it recommends basic protocols using traceable strains, responsible technicians, and clear storage and transportation standards. Production should be limited to personal use, without commercialization, to preserve technical standards and intellectual property rights.

ANPII Bio encourages small producer cooperatives to enable technically and legally appropriate production. For the organization, regulating does not mean restricting, but rather paving the way for affordable, reliable, and sustainable solutions.